OCCX Occulogix (MM)

OccuLogix, Inc. (NASDAQ: OCCX)(TSX: OC) announced that, at its Annual and Special Meeting of Stockholders held today, the stockholders of the Company approved all of the proposals described in the proxy statement for the meeting dated August 29, 2008. OccuLogix currently anticipates the closing of the transactions contemplated by the proposals to occur on or about October 3, 2008, with the proposed reverse stock split of the issued and outstanding shares of the Company's common stock to occur on the business day immediately following the date of closing. The Company's board of directors has set the reverse stock split ratio at 1:25.

About OccuLogix, Inc.

OccuLogix (www.occulogix.com) is a healthcare company focused on ophthalmic devices for the diagnosis and treatment of age-related eye diseases.

Forward-Looking Statements

This press release may contain forward-looking statements. These statements relate to future events and are subject to risks, uncertainties and assumptions about the Company. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. Actual events or results may differ materially. Many factors may cause our actual results to differ materially from any forward-looking statement, including the factors detailed in our filings with the Securities and Exchange Commission and Canadian securities regulatory authorities, including but not limited to our Forms 10-K and 10-Q. We do not undertake to update any forward-looking statements.

Contacts: OccuLogix, Inc. Suh Kim (905) 602-0887, ext. 3915 Email: suh.kim@occulogix.com Website: www.occulogix.com